Wraser Pharmaceuticals Announces Publication of White Paper Addressing Opioid Safety
Sharp rises in opioid abuse and overdose rates in the United States over the past two decades have prompted much-needed review of prescription rates and ease of access to controlled substances. Combatting these alarming trends requires assessing which opioids are more addictive and habit-forming than others. - April 26, 2019
Press Releases 1 - 1 of 1